American journal of obstetrics and gynecology最新文献

筛选
英文 中文
Management of late-onset fetal growth restriction by an antenatal risk stratification protocol. 通过产前风险分层方案管理迟发性胎儿生长受限。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-10 DOI: 10.1016/j.ajog.2025.06.007
Si-Yun Li, Dong-Zhi Li
{"title":"Management of late-onset fetal growth restriction by an antenatal risk stratification protocol.","authors":"Si-Yun Li, Dong-Zhi Li","doi":"10.1016/j.ajog.2025.06.007","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.06.007","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144281972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early gestational diabetes: criticism is based on false premises. 妊娠早期糖尿病:批评是基于错误的前提。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-10 DOI: 10.1016/j.ajog.2025.06.010
Apolonia García-Patterson, Montserrat Balsells, Ivan Solà, Rosa Corcoy
{"title":"Early gestational diabetes: criticism is based on false premises.","authors":"Apolonia García-Patterson, Montserrat Balsells, Ivan Solà, Rosa Corcoy","doi":"10.1016/j.ajog.2025.06.010","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.06.010","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144281970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early gestational diabetes: methodological gaps in the current evidence synthesis. 妊娠早期糖尿病:当前证据合成中的方法学空白。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-10 DOI: 10.1016/j.ajog.2025.06.009
Jiwu Huo, Jianzhong Guan
{"title":"Early gestational diabetes: methodological gaps in the current evidence synthesis.","authors":"Jiwu Huo, Jianzhong Guan","doi":"10.1016/j.ajog.2025.06.009","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.06.009","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144281971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preterm prelabour rupture of membranes: the use of amniocentesis to detect intra-amniotic infection reduces maternal and neonatal duration of antibiotic exposure. 早产产前胎膜破裂:使用羊膜穿刺术检测羊膜内感染可减少产妇和新生儿抗生素暴露的持续时间。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-10 DOI: 10.1016/j.ajog.2025.06.011
Teresa Cobo, Victoria Aldecoa, Silvia Ferrero, Judit Balcells, Ana Lucia Contreras, Andrea Valenzuela, María Pastor, David Boada, Ana Herranz, Montserrat Izquierdo-Renau, Clara Murillo, Ana Del Río, Marta Hernández-Meneses, Berta Fidalgo, Montserrat Rodriguez-Reyes, Francesc Figueras, Eduard Gratacós, Montse Palacio
{"title":"Preterm prelabour rupture of membranes: the use of amniocentesis to detect intra-amniotic infection reduces maternal and neonatal duration of antibiotic exposure.","authors":"Teresa Cobo, Victoria Aldecoa, Silvia Ferrero, Judit Balcells, Ana Lucia Contreras, Andrea Valenzuela, María Pastor, David Boada, Ana Herranz, Montserrat Izquierdo-Renau, Clara Murillo, Ana Del Río, Marta Hernández-Meneses, Berta Fidalgo, Montserrat Rodriguez-Reyes, Francesc Figueras, Eduard Gratacós, Montse Palacio","doi":"10.1016/j.ajog.2025.06.011","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.06.011","url":null,"abstract":"<p><strong>Background: </strong>The current management of patients with preterm prelabor rupture of membranes below 32+0 weeks recommend administering antibiotics although its benefit on the short or long-term neonatal outcome is poor.</p><p><strong>Objective: </strong>To evaluate whether the use of amniocentesis to detect intra-amniotic infection reduces maternal and neonatal duration of antibiotic exposure.</p><p><strong>Methods: </strong>This was a retrospective observational cohort study (2014-2023) including patients diagnosed with preterm prelabor rupture of membranes below 32+0 weeks with an amniocentesis at admission to assess the presence of intra-amniotic infection. We compared two groups according to antenatal management regarding antibiotic treatment. Thus, from 2014-2019, patients were treated at least 5 days with a broad-spectrum antibiotic treatment including intravenous ampicillin and gentamicin, and a single dose of oral azithromycin, regardless of ruling out intra-amniotic infection (standard management group). Beyond 2019, gentamicin was substituted for intravenous ceftriaxone and azithromycin for oral clarithromycin. Antibiotic duration was optimized based on amniotic fluid analysis (amniocentesis-based management): if amniotic fluid glucose concentrations were greater than or equal to 14 mg/dL and Gram staining did not show the presence of bacteria, antibiotic treatment was discontinued at 48 hours. Otherwise, antibiotics were prolonged at least until microbiological amniotic fluid results. Regardless of the management group, if intra-amniotic infection was diagnosed, the type of antibiotic was individualized according to the bacteria isolated and treatment was prolonged for 7-10 days if the delivery did not occur before. There were no other differences in maternal management between the two periods.</p><p><strong>Results: </strong>One hundred seventy-two patients diagnosed with preterm prelabor rupture of membranes below 32+0 weeks were included (122 in the standard management group and 50 in the amniocentesis-based management group). The prevalence of intra-amniotic infection was 29% in both periods, with most (61%) being due to Ureaplasma spp. There were no differences in maternal characteristics between the two groups. As expected, in the amniocentesis-based management group there was shorter maternal exposure to antibiotics (median (25th centile; 75th centile) of 2 (2;3) days (amniocentesis-based management) vs. 5 days (4;5) (standard management), p <0.0001)). In line with the reduction of the duration of antibiotics, we observed that maternal hospital stay was significantly shorter (5 (4; 9) days vs. 11 (5; 21) days, p=0.001), and outpatient management was more frequent (68% vs. 47%, p=0.011). No differences were observed in the in maternal morbidity. Similar results were found when neonatal outcomes were evaluated. Thus, in the amniocentesis-based management group, neonates received less antibiotic treatment at admissi","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144281973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The frequency of placental lesions and adverse pregnancy outcomes: a linked cohort study. 胎盘病变的频率和不良妊娠结局:一项相关队列研究。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-06 DOI: 10.1016/j.ajog.2025.06.004
M C Marijnen, C J M Oudejans, A A Freedman, L M Ernst, W Ganzevoort, M H Schoots, L E van der Meeren, S J Gordijn
{"title":"The frequency of placental lesions and adverse pregnancy outcomes: a linked cohort study.","authors":"M C Marijnen, C J M Oudejans, A A Freedman, L M Ernst, W Ganzevoort, M H Schoots, L E van der Meeren, S J Gordijn","doi":"10.1016/j.ajog.2025.06.004","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.06.004","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intricacies of studying Doula Care. 研究导乐护理的复杂性。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-06 DOI: 10.1016/j.ajog.2025.05.046
Lara S Lemon, Beth Quinn, Hyagriv N Simhan
{"title":"Intricacies of studying Doula Care.","authors":"Lara S Lemon, Beth Quinn, Hyagriv N Simhan","doi":"10.1016/j.ajog.2025.05.046","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.05.046","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Methodological Gaps in Doula Care Research: Recommendations for Enhancing Rigor and Equity in Maternal Health Studies. 解决导乐护理研究方法上的差距:提高孕产妇健康研究的严谨性和公平性的建议。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-06 DOI: 10.1016/j.ajog.2025.05.047
Jisen Zhao, Dong Guo
{"title":"Addressing Methodological Gaps in Doula Care Research: Recommendations for Enhancing Rigor and Equity in Maternal Health Studies.","authors":"Jisen Zhao, Dong Guo","doi":"10.1016/j.ajog.2025.05.047","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.05.047","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of FcγR3A polymorphism in the treatment of gestational trophoblastic tumors. FcγR3A多态性在妊娠滋养细胞肿瘤治疗中的作用。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-05 DOI: 10.1016/j.ajog.2025.06.002
Mengting Zhang, Yong Ni, Lizhong Duan
{"title":"Role of FcγR3A polymorphism in the treatment of gestational trophoblastic tumors.","authors":"Mengting Zhang, Yong Ni, Lizhong Duan","doi":"10.1016/j.ajog.2025.06.002","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.06.002","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of FcγR3A polymorphism in the treatment of gestational trophoblastic tumors. FcγR3A多态性在妊娠滋养细胞肿瘤治疗中的作用。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-05 DOI: 10.1016/j.ajog.2025.05.044
Mengting Zhang, Yong Ni, Lizhong Duan
{"title":"Role of FcγR3A polymorphism in the treatment of gestational trophoblastic tumors.","authors":"Mengting Zhang, Yong Ni, Lizhong Duan","doi":"10.1016/j.ajog.2025.05.044","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.05.044","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal follow-up strategy using high-risk HPV testing and cytology after conservative treatment for cervical adenocarcinoma in situ. 宫颈原位腺癌保守治疗后使用高危HPV检测和细胞学的最佳随访策略。
IF 8.7 1区 医学
American journal of obstetrics and gynecology Pub Date : 2025-06-05 DOI: 10.1016/j.ajog.2025.05.040
M Schaafsma, T N Schuurman, I S van Maurik, R L M Bekkers, P L M Zusterzeel, M C G Bleeker, A G Siebers, C H Mom, J Berkhof, N E van Trommel
{"title":"Optimal follow-up strategy using high-risk HPV testing and cytology after conservative treatment for cervical adenocarcinoma in situ.","authors":"M Schaafsma, T N Schuurman, I S van Maurik, R L M Bekkers, P L M Zusterzeel, M C G Bleeker, A G Siebers, C H Mom, J Berkhof, N E van Trommel","doi":"10.1016/j.ajog.2025.05.040","DOIUrl":"https://doi.org/10.1016/j.ajog.2025.05.040","url":null,"abstract":"<p><strong>Objective: </strong>After treatment for cervical adenocarcinoma in situ (AIS) patients remain at risk for recurrent AIS, high-grade cervical intraepithelial neoplasia, and cervical carcinoma (combined AIS/CIN3+). This study aimed to determine the optimal follow-up strategy for high-risk HPV and cytology testing in conservatively treated patients with AIS.</p><p><strong>Study design: </strong>Patients were selected from a nationwide, retrospective cohort, in which pathology reports from the Dutch Nationwide Pathology databank (Palga) and survival data from the Central Bureau of Genealogy were collected of patients conservatively treated for AIS between 1990 and 2021. The main outcomes were the 5-year cumulative incidence of AIS/CIN3+ stratified by single and consecutive HPV test and/or cytology results at 6, 12, 18 and 24 months.</p><p><strong>Results: </strong>3,411 patients were eligible for analysis. High-risk HPV and/or cytology results in the first 5 years of follow-up were available in 3,312 of 3,411 patients (97.1%), including 5,207 high-risk HPV results of 1,928 patients and 13,369 cytology results of 3,306 patients. Up to 5 years after a single high-risk HPV test at 6months after treatment, AIS/CIN3+ incidence was lower in high-risk HPV negative patients (2.3%, 95%CI: 0.8-3.7) in comparison to high-risk HPV positive patients (20.1%, 95%CI: 14.2-25.5). Patients with normal cytology 6 months after treatment for AIS had a lower incidence of AIS/CIN3+ (3%, 95%CI: 2.2-3.8) in comparison to patients with low-grade (5.9%, 95%CI: 3.4-8.4) or high-grade cytology (52.1%, 95%CI: 42.7-59.9). The 5-year cumulative incidence of AIS/CIN3+ in patients testing negative for high-risk HPV consecutively at 6 and 12, 6 and 18, and 6 and 24 months was 0.6% (95% CI: 0-1.8), 1.1 (95%CI: 0-3.4), and 0% (95% CI not applicable), respectively. Similarly, for patients with consecutive normal co-tests (high-risk HPV negative with normal or low-grade cytology) at 6 and 12, 6 and 18, and 6 and 24 months the 5-year cumulative incidence of AIS/CIN3+ was 0.6% (95% CI: 0-1.8), 1.2 (95%CI: 0-3.5), and 0% (95% CI not applicable), respectively.</p><p><strong>Conclusion: </strong>After two consecutive negative high-risk HPV or normal co-tests within 2 years after conservative AIS treatment, the risk of AIS/CIN3+ is low and it seems acceptable to refer patients back to the national cervical cancer screening program, if applicable.</p>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信